Other CRC patients also highlighted the need to re-assess their brain metastatic tumors through mutational analysis of the CCNDs, KRAS and TSC genes, with loss of the mutation previously also seen for TP53 (Figure 2B). The gene discussed is KRAS; the disease is colorectal carcinoma.